This inventor holds 2 USPTO granted patents and 5 published patent applications. Active years: 2024-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Years Active: 2024-2025
Title: Innovations in Cancer Treatment by Nimra Naveed Shaikh
Introduction
Nimra Naveed Shaikh is a prominent inventor based in Karachi, Pakistan. She has made significant contributions to the field of cancer research, particularly in the development of potent aromatase inhibitors for the treatment of estrogen-positive breast cancer. With a total of 2 patents, her work is paving the way for new therapeutic options in oncology.
Latest Patents
Nimra's latest patents include the synthesis of a potent aromatase inhibitor, 17α-acetoxy-10β,11β-dihydroxy-progesterone, which has shown promise in treating ER+ breast cancer. This compound was identified as a non-cytotoxic inhibitor of the human aromatase enzyme, demonstrating significant aromatase inhibitory activity compared to the standard drug exemestane. Another notable patent involves the biotransformation of the anti-cancer drug testolactone, yielding several metabolites that exhibit potent inhibition against the aromatase enzyme. These findings highlight the potential of her compounds as therapeutic agents against ER+ breast cancers.
Career Highlights
Throughout her career, Nimra has focused on the biotransformation of existing drugs to enhance their efficacy against breast cancer. Her innovative approach has led to the identification of several metabolites that could serve as effective treatments. Her research not only contributes to the scientific community but also aims to improve patient outcomes in breast cancer therapy.
Collaborations
Nimra has collaborated with notable researchers, including Muhammad Iqbal Choudhary and Humaira Zafar. These partnerships have enriched her research and expanded the impact of her work in the field of cancer treatment.
Conclusion
Nimra Naveed Shaikh's contributions to cancer research through her innovative patents are significant. Her work on aromatase inhibitors represents a promising advancement in the fight against breast cancer. The potential therapeutic applications of her discoveries could lead to improved treatment options for patients worldwide.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile